Mutual of America Capital Management LLC boosted its position in shares of Mednax, Inc (NYSE:MD) by 1.5% in the second quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 74,817 shares of the company’s stock after acquiring an additional 1,140 shares during the period. Mutual of America Capital Management LLC owned 0.08% of Mednax worth $4,517,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other large investors have also recently bought and sold shares of the stock. PNC Financial Services Group Inc. lifted its position in Mednax by 0.5% during the first quarter. PNC Financial Services Group Inc. now owns 9,099 shares of the company’s stock valued at $632,000 after acquiring an additional 47 shares during the last quarter. Pacer Advisors Inc. lifted its position in Mednax by 3.2% during the first quarter. Pacer Advisors Inc. now owns 1,795 shares of the company’s stock valued at $125,000 after acquiring an additional 55 shares during the last quarter. Nomura Asset Management Co. Ltd. lifted its position in Mednax by 1.3% during the first quarter. Nomura Asset Management Co. Ltd. now owns 11,300 shares of the company’s stock valued at $784,000 after acquiring an additional 140 shares during the last quarter. State Treasurer State of Michigan lifted its position in Mednax by 0.5% during the second quarter. State Treasurer State of Michigan now owns 38,300 shares of the company’s stock valued at $2,312,000 after acquiring an additional 200 shares during the last quarter. Finally, Arizona State Retirement System lifted its position in Mednax by 0.5% during the second quarter. Arizona State Retirement System now owns 39,200 shares of the company’s stock valued at $2,367,000 after acquiring an additional 200 shares during the last quarter.

WARNING: “Mutual of America Capital Management LLC Has $4.52 Million Position in Mednax, Inc (MD)” was originally published by Daily Political and is owned by of Daily Political. If you are viewing this article on another domain, it was illegally copied and republished in violation of U.S. and international trademark and copyright law. The legal version of this article can be viewed at https://www.dailypolitical.com/2017/09/24/mutual-of-america-capital-management-llc-has-4-52-million-position-in-mednax-inc-md.html.

In other news, insider John C. Pepia sold 3,000 shares of the business’s stock in a transaction that occurred on Tuesday, September 12th. The shares were sold at an average price of $42.85, for a total transaction of $128,550.00. Following the completion of the sale, the insider now owns 35,569 shares in the company, valued at approximately $1,524,131.65. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. 2.40% of the stock is currently owned by insiders.

A number of equities research analysts recently commented on the stock. Mizuho reissued a “neutral” rating and set a $48.00 target price (down previously from $62.00) on shares of Mednax in a research report on Tuesday, August 1st. KeyCorp raised shares of Mednax from a “sector weight” rating to an “overweight” rating and set a $51.00 target price for the company in a research report on Sunday, September 17th. Jefferies Group LLC set a $46.00 target price on shares of Mednax and gave the company a “hold” rating in a research report on Sunday, July 30th. BidaskClub raised shares of Mednax from a “strong sell” rating to a “sell” rating in a research report on Tuesday, June 13th. Finally, ValuEngine cut shares of Mednax from a “buy” rating to a “hold” rating in a research report on Friday, June 2nd. Two research analysts have rated the stock with a sell rating, ten have issued a hold rating and two have issued a buy rating to the company’s stock. The stock currently has an average rating of “Hold” and an average price target of $58.89.

Mednax, Inc (NYSE:MD) opened at 42.14 on Friday. Mednax, Inc has a 52 week low of $40.78 and a 52 week high of $72.13. The firm’s 50-day moving average is $43.21 and its 200-day moving average is $56.37. The firm has a market cap of $3.88 billion, a price-to-earnings ratio of 13.42 and a beta of 0.40.

Mednax (NYSE:MD) last issued its quarterly earnings data on Friday, July 28th. The company reported $0.85 earnings per share for the quarter, topping the consensus estimate of $0.81 by $0.04. The business had revenue of $843.00 million during the quarter, compared to the consensus estimate of $849.49 million. Mednax had a net margin of 8.78% and a return on equity of 11.89%. The company’s revenue was up 9.2% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $1.03 EPS. On average, equities analysts anticipate that Mednax, Inc will post $3.31 earnings per share for the current year.

Mednax Profile

MEDNAX, Inc is a provider of physician services, including newborn, anesthesia, maternal-fetal, teleradiology, pediatric cardiology and other pediatric subspecialty care. As of December 31, 2016, the Company’s national network consisted of over 3,600 affiliated physicians, including over 1,130 physicians providing neonatal clinical care, in 35 states and Puerto Rico, primarily within hospital-based neonatal intensive care units (NICUs), to babies born prematurely or with medical complications.

Institutional Ownership by Quarter for Mednax (NYSE:MD)

Receive News & Ratings for Mednax Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mednax Inc and related companies with MarketBeat.com's FREE daily email newsletter.